XML 143 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivative Instruments - Summary of the Effect of Derivatives Designated as Net Investment Hedging Instruments (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2022
Feb. 29, 2012
Samsung Bioepis        
Derivative Instruments, Gain (Loss) [Line Items]        
Ownership percentage     49.90% 15.00%
Net investment hedge        
Derivative Instruments, Gain (Loss) [Line Items]        
Net Gains/(Losses) Recognized in Other Comprehensive Income (Effective Portion) (in millions) $ 20.4 $ 46.0    
Net Gains/(Losses) Recognized in Other Comprehensive Income (Amounts Excluded from Effectiveness Testing) (in millions) (3.2) (3.2)    
Net investment hedge | Other (income) expense, net        
Derivative Instruments, Gain (Loss) [Line Items]        
Net Gains/(Losses) Recognized in Net Income (Amounts Excluded from Effectiveness Testing) (in millions) $ (4.6) $ (0.6)